Identification of specific inflammatory markers might indicate the proper timing for hernia repair: Serial monitoring of CRP, IL-6, and other inflammatory biomarkers during GLP-1 therapy may help determine optimal surgical timing when inflammatory burden is minimized [79]. This evidence concerns the gene GLP1R and Hernia.